Abstract:The low solubility and slow dissolution of hydrophobic drugs is a major challenge for the pharmaceutical industry. In this paper, we present the synthesis of surface-functionalized poly(lactic-co-glycolic acid) (PLGA) nanoparticles for incorporation into corticosteroid dexamethasone to improve its in vitro dissolution profile. The PLGA crystals were mixed with a strong acid mixture, and their microwave-assisted reaction led to a high degree of oxidation. The resulting nanostructured, functionalized PLGA (nfPLGA), was quite water-dispersible compared to the original PLGA, which was non-dispersible. SEM-EDS analysis showed 53% surface oxygen concentration in the nfPLGA compared to the original PLGA, which had only 25%. The nfPLGA was incorporated into dexamethasone (DXM) crystals via antisolvent precipitation. Based on SEM, RAMAN, XRD, TGA and DSC measurements, the nfPLGA-incorporated composites retained their original crystal structures and polymorphs. The solubility of DXM after nfPLGA incorporation (DXM–nfPLGA) increased from 6.21 mg/L to as high as 87.1 mg/L and formed a relatively stable suspension with a zeta potential of −44.3 mV. Octanol–water partitioning also showed a similar trend as the logP reduced from 1.96 for pure DXM to 0.24 for DXM–nfPLGA. In vitro dissolution testing showed 14.0 times higher aqueous dissolution of DXM–nfPLGA compared to pure DXM. The time for 50% (T50) and 80% (T80) of gastro medium dissolution decreased significantly for the nfPLGA composites; T50 reduced from 57.0 to 18.0 min and T80 reduced from unachievable to 35.0 min. Overall, the PLGA, which is an FDA-approved, bioabsorbable polymer, can be used to enhance the dissolution of hydrophobic pharmaceuticals and this can lead to higher efficacy and lower required dosage.

Preparation and characterization of Dexamethasone acetate loaded PEG-PLGA nanoparticles

Methoxy Poly（ethylene Glycol）-B-poly（ethyl Cyanoacrylate） Copolymer Nanoparticles As Delivery Vehicles for Dexamethasone

The Preparation of Dexamethasone Acetate Lipid Nanoparticles

Poly(trimethylene Carbonate) and Monomethoxy Poly(ethylene Glycol)-Block-poly(trimethylene Carbonate) Nanoparticles for the Controlled Release of Dexamethasone.

Preparation and in Vivo Pharmacokinetics of Polyethylene Glycol-Modified Nanoparticles Loaded with Dexamethasone Acetate

OPTIMIZATION OF PREPARATION OF DEXAMETHASONE ACETATE-LOADED POLY(D,L-LACTIDE) MICROSPHERES BY CENTRAL COMPOSITE DESIGN

Preparation and in vitro characterization of microspheres containing dexamethasone sodium phosphate

Preparation and optimization of dexamethasone acetate solid lipid nanoparticles by orthogonal design

Optimization of the technological process to prepare Dexamethasone solid lipid nanoparticles

A Novel Strategy for Encapsulating Poorly Soluble Drug into Nanostructured Lipid Carriers for Intravenous Administration

Preparation and Evaluation of Microencapsulated Dexamethasone Sodium Phosphate Using Double Emulsion Method

Design and characterization of dexamethasone phosphate -loaded microcapsules obtained by a double-emulsion method

Preparation, Characterization, and in Vitro Evaluation of Docetaxel-Loaded Poly(lactic Acid)-Poly(ethylene Glycol) Nanoparticles for Parenteral Drug Delivery.

PLA/F68/Dexamethasone Implants Prepared by Hot-Melt Extrusion for Controlled Release of Anti-Inflammatory Drug to Implantable Medical Devices: I. Preparation, Characterization and Hydrolytic Degradation Study

Preparation and characterization of hyaluronic acid-modified dexamethasone core-shell liponanoparticles

Optimization of preparation of DHAQ-loaded PEG-PLGA-PEG nonaparticles using central composite design

Optimization of the technological process to prepare Dexamethasone acetate lipid nanoparticles using central composite design-response surface methodology

PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate

Production of antihyerglycemic and antihypertensive drug loaded sustained release nanoparticles using spray drying technique: Optimization by Placket Burman Design

Synthesis of Microwave Functionalized, Nanostructured Polylactic Co-Glycolic Acid (nfPLGA) for Incorporation into Hydrophobic Dexamethasone to Enhance Dissolution

Release characteristics of dexamethasone acetate solid lipid nanoparticles lyophilized power in vitro